Sign in

Naoka Murakami

@nymurakami.bsky.social
1K followers 424 following 2 posts

Transplant nephrology, immunology, Onconephrology Assistant Professor @ WashU St Louis

PostsRepliesMedia
Naoka Murakami @nymurakami.bsky.social · 25/09/2026
AST Fellows Symposium 2026 kicked off! Wonderful lectures from experts on Why and How of Transplant, and Basic Immunology and more! @astinfo.bsky.social
040
Reposted by Naoka Murakami
American Journal of Kidney Diseases @ajkd.bsky.social · 06/07/2026
Kidney Transplant Clinicians’ Perceptions of Palliative Care for Patients With Failing Allografts in the US: A Mixed Methods Study bit.ly/3rNOKOf (FREE temporarily)
bit.ly
Kidney Transplant Clinicians’ Perceptions of Palliative Care for Patients With Failing Allografts in the US: A Mixed Methods Study
Kidney transplant patients with failing allografts have a physical and psychological symptom burden as well as high morbidity and mortality. Palliative care is underutilized in this vulnerable populat...
121
Reposted by Naoka Murakami
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 26/01/2026
February calendar for @uottawa.ca nephrology program @nymurakami.bsky.social on plasma cell disorders Januvi Jegatheswaran on hypertension education and much more #NephJC
feb calendar
031
Reposted by Naoka Murakami
American Journal of Kidney Diseases @ajkd.bsky.social · 22/08/2025
Exercise-Based Prehabilitation for Kidney Transplant Candidates: The FRAILMar Randomized Controlled Trial bit.ly/P%C3%A9rez-S... @mjoseperezsaez.bsky.social
063
Reposted by Naoka Murakami
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 30/07/2025
Plasma cell dyscrasia and transplant - excellent review in @kidneyint.bsky.social www.kidney-international.org/article/S008... From @nymurakami.bsky.social et al #NephSky #OncoNeph
Figure 1 Timing of recurrence of various plasma cell dyscrasia in kidney transplant allograft. LCCN: light chain cast nephropathy, LCPT: light chain proximal tubulopathy, C3G: C3 glomerulopathy, PGNMID: proliferative glomerulitis with immunoglobulin depositsFigure 2 Decision Tree for MM Patients with ESKD Based on Risk Category and Response to Therapy
0123
Reposted by Naoka Murakami
Needhi Bhalla 💅🏽 @needhibhalla.bsky.social · 10/03/2025
so the EO should not be affecting the funding of NIH grants, is that correct?
410119
Reposted by Naoka Murakami
Alt NIH Bluesky 🧪 @altnih4science.bsky.social · 14/02/2025
It’s been buried in all the news today, but every scientist in the US should pay attention to this: Mike Lauer went out on a limb for us all, sending out a memo saying institutes should start awarding grants. And it looks like Trump/Musk fired him for that. 🧪
201360594
Reposted by Naoka Murakami
Hofstra Kidney @hofstrakidney.bsky.social · 02/12/2024
SUrvey of renal biopsy registry database and anticancer dRUg therapy in japan (SUBARU-J study) academic.oup.com/ckj/advance-... @kdjhaveri.bsky.social
academic.oup.com
SUrvey of renal biopsy registry database and anticancer dRUg therapy in japan (SUBARU-J study)
AbstractBackground. Kidney complications associated with anticancer-drug therapy have greatly increased recently. We aimed to investigate the real-world cl
074
Reposted by Naoka Murakami
WashU Nephrology @washunephrology.bsky.social · 25/11/2024
"Sister Clinic Programs" @washunephrology.bsky.social & #IGSS host 6th #Nephrology Symposium in beautiful #Antigua.📣 Vincente Polo, Tingting LI, Gonzalo Matzumura, Massini Murzkani, Ignacio Castillo, Marcos Rothstein, Charbel Khoury& @vijayanmd.bsky.social. #ISN nephrology.wustl.edu/washu-nephro...
nephrology.wustl.edu
WashU Nephrology and IGSS Gather in Guatemala for 6th Annual Nephrology Symposium  - Division of Nephrology
The beautiful, former colonial capitol of Central America, Antigua, Guatemala, was the setting for the highly anticipated 6th Annual Nephrology Symposium, a collaboration between Washington University...
062